BIO Investor Forum to host over 100 presenting companies.
Press Release Summary:
August 28, 2014 - BIO has announced initial list of presenting companies for the 13th Annual BIO Investor Forum. International event assembles early and established private companies as well as emerging public biotechs, along with top public and private equity investors, to explore investment trends and opportunities in life sciences. Presenting companies have clear research and development focus with a pipeline involving biotechnology for therapeutics, diagnostics, or platform technologies.
Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900, Washington, DC, 20024, USA
Original Press Release
The 13th Annual BIO Investor Forum to Host Over 100 Presenting Companies
Press release date: August 25, 2014
Presentations will feature biotech companies poised to join the growth “watch list” in 2015
13th Annual BIO Investor Forum
WASHINGTON -- The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the 13th Annual BIO Investor Forum. The event is an international investor forum that assembles early and established private companies as well as emerging public biotechs, along with top public and private equity investors, to explore investment trends and opportunities in life sciences. The event will take place October 7-8, 2014 at the Palace Hotel in San Francisco, California.
“Investors are eager to learn about and evaluate fresh new investment opportunities, as evidenced by the 30% increase in investor registration to date compared to last year.”
“Over the past three years, more than 30 of the private companies that presented at a BIO Investor Forum have gone public, generating a current combined market capitalization of nearly $15 billion,” said Jim Greenwood, CEO and President at BIO. “Investors are eager to learn about and evaluate fresh new investment opportunities, as evidenced by the 30% increase in investor registration to date compared to last year.”
Presenting companies have a clear R&D focus with a pipeline involving biotechnology for therapeutics, diagnostics or platform technologies. More than one-quarter of the public presenting companies at the event have gone public since passage of the Jumpstart Our Business Startups (JOBS) Act in April 2012. To date, overall, 111 biotech companies have gone public since passage of the JOBS Act.
New presenting companies are continuously being added. For updates on the list of presenters, please visit here. If you are interested in becoming a presenter, please submit an application here.
The following companies will present at the 13th Annual BIO Investor Forum:
Critical Outcome Technologies Inc.
Protagonist Therapeutics, Inc.
Vivaldi Biosciences Inc.
Catalyst Pharmaceutical Partners
Critical Outcome Technologies
Newron Pharmaceuticals SpA
*Denotes companies who went public since passage of the JOBS Act
Now a staple at the BIO Investor Forum, the event will again host a series of Discovery Track presentations that feature Seed and A-round companies incorporated after 2009 and have raised less than $25M through October 2014. Companies in this track are also first-time presenters and use biotechnology or related technologies for research and development of drug products or diagnostics. The following companies are scheduled to present in the Discovery Track:
ETX Pharma, Inc.
Also presenting in the Discovery Track will be several patient advocacy groups looking for potential research partners:
Juvenile Diabetes Research Foundation
Rare Cancer Research Foundation
New to BIO Investor Forum this year, the Buzz of BIO contest is recognizing “Early Stage Entrepreneurs” and “Late Stage Leaders.” One winner from each category will receive complimentary registration and a company presentation opportunity. Voting opens today, August 25, and winners will be selected by number of votes, on September 4, 2014. Nominees include:
Early Stage Entrepreneur:
Late Stage Leader:
Enable Injections, LLC
To learn more about the BIO Investor Forum, including registration, program and partnering information, please visit here. Media registration is now open for qualified members of the press.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Upcoming BIO Events
BIO Latin America Conference
September 9-11, 2014
Rio de Janeiro, Brazil
Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD
BIO Investor Forum
October 7-8, 2014
San Francisco, CA
BIO Europe 2014
November 3-5, 2014
BIO IPCC Conference
November 10-12, 2014
BIO Pacific Rim Summit on Industrial Biotechnology & Bioenergy
December 7-9, 2014
San Diego, CA
BIO International Convention
June 15-18, 2015
Biotechnology Industry Organization
Abigail Hirsch, 202-962-9230